Pacira Pharmaceuticals, Inc
Pacira BioSciences is dedicated to transforming pain management through innovative, non-opioid therapies. The company focuses on developing targeted solutions for chronic, postsurgical, and musculoskeletal pain, emphasizing safety and efficacy. With a mission to improve patient lives, Pacira leads in research, advocacy, and global access to safer pain relief options, aiming to reduce opioid reliance and expand treatment accessibility worldwide.
Industries
Nr. of Employees
large (251-1000)
Pacira Pharmaceuticals, Inc
Patents
Products
Liposomal extended-release local anesthetic injectable
An injectable extended‑release local anesthetic formulation using liposome-based technology for postsurgical pain control.
Extended-release intra-articular corticosteroid injectable
An extended‑release injectable corticosteroid formulation intended for intra-articular use to manage joint pain.
Device-based localized pain therapy system
A commercially supported medical device system for localized pain management delivered through a device franchise and associated clinical support.
Liposomal extended-release local anesthetic injectable
An injectable extended‑release local anesthetic formulation using liposome-based technology for postsurgical pain control.
Extended-release intra-articular corticosteroid injectable
An extended‑release injectable corticosteroid formulation intended for intra-articular use to manage joint pain.
Device-based localized pain therapy system
A commercially supported medical device system for localized pain management delivered through a device franchise and associated clinical support.
Services
Phone and email channels for medical inquiries, technical assistance, and adverse event reporting.
Operational support for reimbursement-related inquiries to facilitate patient access.
Execution support for clinical studies and collaborative research partnerships across the company's pipeline.
Patient-facing educational content, film and resource hubs to support shared decision-making and awareness of non-opioid options.
Partnership engagement, advocacy funding, and product donations to support medical missions and expand global access.
Phone and email channels for medical inquiries, technical assistance, and adverse event reporting.
Operational support for reimbursement-related inquiries to facilitate patient access.
Execution support for clinical studies and collaborative research partnerships across the company's pipeline.
Patient-facing educational content, film and resource hubs to support shared decision-making and awareness of non-opioid options.
Partnership engagement, advocacy funding, and product donations to support medical missions and expand global access.
Expertise Areas
- Clinical trial management
- Non-opioid analgesic development
- Extended-release injectable formulation development
- Multivesicular liposome drug-delivery
Key Technologies
- Multivesicular liposome (MVL) drug delivery
- Liposomal extended-release injectable formulations
- Extended-release intra-articular corticosteroid formulations
- Gene therapy platforms for pain